EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc announces that further to yesterday’s announcement regarding the significant increase in manufacturing demand for the PrimeStore MTM sample collection device

EKF Diagnostics Holdings plc provides an update on the significant increase in manufacturing demand from Longhorn Vaccines and Diagnostics LLC  in the US.

EKF Diagnostics Holdings plc announces its final results for the year ended 31 December 2019.

EKF Diagnostics Holdings plc provides shareholders with an update on current trading in light of the COVID-19 pandemic

EKF Diagnostics will announce its preliminary results for the year ended 31 December 2019 on Tuesday 24 March 2020.

EKF Diagnostics announces that it will release its preliminary results for the year ended 31 December 2019 on Tuesday 24 March 2020.

Standard form for notification of major holdings. 

EKF Diagnostics provides the following the trading update for the year ended 31 December 2019.

EKF Diagnostics provides shareholders with the following update on current trading and performance bonuses.

EKF Diagnostics announces that it has entered into a non-exclusive Preferred Partner Arrangement with Mount Sinai Innovation Partners.